Wolverine Asset Management LLC Acadia Pharmaceuticals Inc Transaction History

Wolverine Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $56,144 - $123,397	-2,244 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $92,093 - $127,436	2,244 New	2,244 $119,000
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $1,456 - $2,280	-40 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $1,570 - $2,109	40 New	40 $1,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.